1069183--3/16/2009--TASER_INTERNATIONAL_INC

related topics
{customer, product, revenue}
{property, intellectual, protect}
{product, liability, claim}
{cost, regulation, environmental}
{product, market, service}
{personnel, key, retain}
{stock, price, operating}
{operation, international, foreign}
{financial, litigation, operation}
{competitive, industry, competition}
{control, financial, internal}
{loss, insurance, financial}
To the extent demand for our products increases, our future success will be dependent upon our ability to ramp manufacturing production capacity which will be accomplished by the implementation of customized manufacturing automation equipment. Pending litigation may subject us to significant litigation costs, judgments, fines and penalties in excess of insurance coverage, and divert management attention from our business. Our future success is dependent on our ability to expand sales through distributors and our inability to recruit new distributors would negatively affect our sales. If we are unable to design, introduce and sell new products or new product features successfully, our business and financial results could be adversely affected. We expend significant resources in anticipation of a sale due to our lengthy sales cycle and may receive no revenue in return. Government regulation of our products may adversely affect sales. Environmental laws and regulations subject us to a number of risks and could result in significant liabilities and costs. If we are unable to protect our intellectual property, we may lose a competitive advantage or incur substantial litigation costs to protect our rights. We may be subject to intellectual property infringement claims, which could cause us to incur litigation costs and divert management attention from our business. If we face competition in foreign countries, we can enforce patent rights only in the jurisdictions in which our patent applications have been granted. Our efforts to avoid the patent, trademark, and copyright rights of others may not provide notice to us of potential infringements in time to avoid investing in product development and promotion that must later be abandoned if suitable license terms cannot be reached. Government regulations applied to our products may affect our markets for these products. Competition in the law enforcement and corrections market could reduce our sales and prevent us from achieving profitability. Defects in our products could reduce demand for our products and result in a loss of sales, delay in market acceptance and injury to our reputation. Our dependence on third party suppliers for key components of our devices could delay shipment of our products and reduce our sales. Component shortages could result in our inability to produce volume to adequately meet customer demand. This could result in a loss of sales, delay in deliveries and injury to our reputation. Our dependence on foreign suppliers for key components of our products could delay shipment of our finished products and reduce our sales. We may experience a decline in gross margins due to rising raw material and transportation costs associated with a future increase in petroleum prices. Our revenues and operating results may fluctuate unexpectedly from quarter to quarter, which may cause our stock price to decline. We may experience difficulties in the future in complying with Sarbanes-Oxley Section 404. Foreign currency fluctuations may affect our competitiveness and sales in foreign markets. We maintain all of our cash, cash equivalent and short-term investment balances, some of which are not insured, at one depository institution. Use of estimates may cause our financial results to differ from expectations. We face risks associated with rapid technological change and new competing products. We depend on our ability to attract and retain our key management and technical personnel.

Full 10-K form ▸

related documents
1069183--3/15/2010--TASER_INTERNATIONAL_INC
1069183--2/29/2008--TASER_INTERNATIONAL_INC
1069183--3/15/2007--TASER_INTERNATIONAL_INC
903129--2/19/2010--AMERIGON_INC
868368--12/12/2008--ROCHESTER_MEDICAL_CORPORATION
917520--3/3/2009--INTEGRA_LIFESCIENCES_HOLDINGS_CORP
1324759--3/31/2009--Cereplast_Inc
4127--11/29/2010--SKYWORKS_SOLUTIONS_INC
313927--2/24/2010--CHURCH_&_DWIGHT_CO_INC_/DE/
1014672--3/14/2008--CALIPER_LIFE_SCIENCES_INC
1014672--3/13/2009--CALIPER_LIFE_SCIENCES_INC
811240--3/19/2010--BIOLASE_TECHNOLOGY_INC
820237--2/25/2008--GEN_PROBE_INC
933974--11/23/2010--BROOKS_AUTOMATION_INC
868368--12/11/2009--ROCHESTER_MEDICAL_CORPORATION
868368--12/10/2010--ROCHESTER_MEDICAL_CORPORATION
772406--6/1/2009--CIRRUS_LOGIC_INC
897067--2/27/2009--CYMER_INC
4127--11/30/2009--SKYWORKS_SOLUTIONS_INC
4127--12/2/2008--SKYWORKS_SOLUTIONS_INC
820237--3/13/2006--GEN_PROBE_INC
1275014--3/19/2009--ULTRA_CLEAN_HOLDINGS_INC
933974--11/18/2009--BROOKS_AUTOMATION_INC
917520--3/1/2010--INTEGRA_LIFESCIENCES_HOLDINGS_CORP
915779--6/17/2009--DAKTRONICS_INC_/SD/
802356--6/9/2008--PARLUX_FRAGRANCES_INC
772406--6/1/2010--CIRRUS_LOGIC_INC
103145--2/24/2010--VEECO_INSTRUMENTS_INC
1311538--6/29/2009--Castle_Brands_Inc
57725--9/24/2010--LANNETT_CO_INC